Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

NCT04569032

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford Cancer Center Stanford, California, United States
  • Stanford Hospital and Clinics, Investigational Drug Services Stanford, California, United States
View all 63 locations
View Trial Details
Completed

A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

NCT03332017

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Illinois At Chicago Chicago, Illinois, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • Duke University Durham, North Carolina, United States
View all 88 locations
View Trial Details
Completed

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

NCT05894954

Conditions
Alzheimer Disease, Anomia, Brain Diseases, +27 more
Locations
  • True Health Center for Functional Medicine Folsom, California, United States
  • Ann Hathaway, MD San Rafael, California, United States
  • Bay Area Wellness Walnut Creek, California, United States
  • Rezilir Health Hollywood, Florida, United States
View Trial Details
Completed

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

NCT01516580

Conditions
B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +16 more
Locations
  • University Hospitals Leuven Leuven, Belgium
  • Children Oncology Group Operations centres Monrovia, Canada
  • The University of Hong Kong (Clinical Trials Centre) Hong Kong, China
  • Institut de Cancérologie Gustave roussy Villejuif, France
View Trial Details

Related conditions